Medical Oncology Education Research Articles

Global interest in podcasts designed for medical oncology trainees.

9019 Background: Audio podcasts allow for medical education to be disseminated in an on-demand format and are globally accessible. There are currently a limited number of trainee-directed medical oncology podcasts and their global impact has not been shown. “Talking about Tumors with Ryann and Ryan” is an English language, evidence-based, free-to-use podcast that was initiated in April 2022 with a focus on education of trainees new to the field. Methods: Geographic statistics were collected for podcast episodes with greater than 30 days of availability. The proportion of listeners from different regions was compared between episodes. Trends in listeners from North America and global audiences were descriptively analyzed. Results: 34 episodes were included in this analysis, with content in gastrointestinal, breast, thoracic and cutaneous malignancies. Episodes had a median of 115 downloads, with consistently >30% from outside of Canada and the United States (median 37.3 +/- 6.4%). Twenty-four countries had greater than 10 downloads. The largest audience beyond North America was Australia (13%), Israel (4%), United Kingdom (3%), Pakistan (3%), Sweden (2%), India (1%), and Hong Kong (1%). A review of individual cities within countries was relatively constant, suggestive of persistent listenership. Conclusions: There is a global interest for introductory medical oncology education. Presentation in an evidence-based format and awareness of variation in regional approaches to systemic therapy can increase the impact of podcasts, which by their design can reach a global audience. The development of an index for early education oncology podcasts may improve visibility and access to those interested in this medium.

Medical oncology perception among medical students and interns in Saudi Arabia

Objective: This study assessed Saudi medical students' and interns' perceptions, and medical education related to oncology, in addition to providing suggestions to enhance these areas from students' and interns' perspectives. Furthermore, to determine which factors influence the quality of their education and their interest in being future medical oncologists. Methods: A cross-sectional, descriptive study was carried out among medical students and interns in Saudi Arabia in August 2022. Using Google documents, an electronically distributed, self-administered questionnaire was designed to assess students' and interns' medical oncology education, interest, and perception. Results: Approximately 422 eligible responses were obtained from medical students and interns across Saudi Arabia. Participants who have received medical oncology education theoretically alone or without the involvement of an oncologist evaluated their education as poorer than the ones who received it clinically or with the involvement of an oncologist (p-values = 0.002,

Exploring the Inner Lens: Examining Oncology Consultants' Use of Competency and Assessment Frameworks in Clinical Teaching Settings.

Medical education in oncology has adopted a competency-based medical education (CBME) approach in Canada. Oncologist competencies are arranged within assessment frameworks, but it is unknown whether oncologists routinely use assessment frameworks when determining what to teach oncology trainees. Understanding oncologists' actual approaches to assessment and teaching as a form of enacted CBME could inform and focus faculty development efforts. Using a participatory action research approach, oncology faculty were interviewed regarding their teaching practices and use of assessment frameworks. Faculty suggestions regarding challenges in setting teaching goals and completing assessment within the CBME paradigm were solicited. Furthermore, teaching objectives developed by faculty in-house were assessed regarding the domains of competence targeted. Thirty-one of the 40 faculty members in the Department of Oncology, Western University, agreed to participate. Trainee factors (training level, areas of interest), faculty personal values and experience, the teaching setting, and some components of frameworks (medical expert, communicator, advocate, and professional) were articulated as determinants of teaching goals. Of the 1117 in-house objectives reviewed, 76% focused on the medical role. Faculty held widely disparate views on assessment framework features which would enable teaching and assessment. Oncology faculty members used a multifaceted approach to determine what to teach trainees. This approach contains elements both of the conventional apprenticeship models under which many faculty members themselves were trained and of the CBME paradigm. Future research should focus on exploring ways to resolve the tension between established individual teaching approaches and nationally standardized competency frameworks which are being implemented.

Assessing the landscape in medical oncology medical education scholarship: A scoping study.

11009 Background: Medical oncology and medical education have both expanded exponentially over the past 50 years; as such, it is important to understand the current status of postgraduate medical oncology education and develop ways to advance this field. This study undertakes a scoping review of medical education literature in medical oncology to inform future scholarship in this area. Methods: MEDLINE (Ovid), Embase (Ovid), ERIC (EBSCO), and Web of Science (UBC Core Collection) were searched to find peer-reviewed English language articles on Postgraduate Medical Education in Medical Oncology published between 2009 and 2020. The review was designed in accordance with updated methodological guidance for the conduct of scoping review. Articles were classified by learning specialty, learner training level, region of authorship, single or multi-institution, year of publication, whether the journal was an education journal, quantitative vs qualitative design, study methodology, and category or topic. A modified Kerns framework for curriculum development was used to assess the type of curriculum intervention, Boyer’s definition of scholarship was used to classify the type of scholarship, and the CanMEDS Framework was used to map the domains of physician competency each study aims to address. Results were interpreted using descriptive statistics and collated and summarized utilizing predetermined conceptual frameworks. Results: 2959 references were initially found across the 4 databases. After title and abstract screening, 305 articles remained; after full text review, a total of 144 articles were included in our final analysis. These data showed that postgraduate medical oncology graduate medical education scholarship is increasing and most commonly observed in the United States. Quantitative studies were most common with surveys used as the most popular study approach. In terms of CanMEDS framework, Professional and Medical Expert comprised the large majority of education focuses, while very few articles addressed Leader or Health Advocate. Curriculum development, professional development, and attitudinal skills (communication skills, ethics) were the dominant research themes, while no articles discussed teacher training. Conclusions: By investigating the body of current literature, this research identifies areas of highest priority in postgraduate medical oncology graduate medical education and opportunities for growth. Whereas areas like professionalism and attitudinal skills are well-studied, research is lacking in leadership, health advocacy and teaching training. This study provides guidance for future medical education scholarship in medical oncology and establishes a benchmark to examine changes in medical oncology educational scholarship over time.

A Successful Model for an Introductory Oncology Teaching Conference and Its Impact on Preclinical and Clinical Medical Students.

Oncology education at medical schools is often fragmented, under-represented, and nonstandardized. Medical students lack essential knowledge, skills, and attitudes necessary for them to provide optimal primary care to patients with cancer upon graduation. In this study, we designed and assessed the impact of a compact oncology teaching conference on medical students. The conference covered topics in cancer biology, public health, diagnosis, patient management, treatment, and communication skills. Medical students completed voluntary presurveys and postsurveys regarding their perceived knowledge, attitudes, and perspectives. The event was promoted by student groups, particularly our ASCO Oncology Student Interest Group, and took place online. A total of 228 responses from medical students representing 50 universities were analyzed. We revealed significant baseline confidence and perceived knowledge deficits especially in diagnosis and patient management, and treatment modalities. Our conference positively affected self-assessed knowledge acquisition among students, with the most pronounced differences seen in diagnosis and patient management (2.51 ± 1 v 3.87 ± 0.81) and treatment modalities (2.54 ± 0.96 v 3.79 ± 0.88), P < .001. Students believed the program was beneficial, felt more confident in applying their knowledge in the clinic and in delivering bad news, and were more interested in pursuing oncology-related fields, P < .001. We demonstrated that a compact teaching conference resulted in significant improvements in students' confidence and perceived knowledge about oncology. Our successful teaching model can be adapted and implemented at medical schools globally. Development and evaluation of teaching programs are important to urgently reform undergraduate medical education in oncology.

Clinical Objectives of the Canadian Licensing Examination: Exploring the Representation of Oncology.

Every physician should be comfortable caring for cancer patients, yet medical education in oncology is known as inadequate. Our study explored this issue from an assessment perspective, by determining the representation of oncology and other health priorities in the clinical learning objectives for the Medical Council of Canada Qualifying Examination Part 1 (MCCQE Part 1). The Medical Council of Canada lists objectives for the MCCQE Part 1, based on CanMEDS roles for medical graduate competency. These objectives guide exam question development and can be used as a study guide for learners. Our study focused on the Medical Expert role and mapped the clinical objectives for oncologic, cardiovascular, cerebrovascular and chronic lower respiratory disease. The clinical objectives contained 190 topics under the Medical Expert role. Oncology content was found in 57 (30%), cardiovascular disease in 56 (29.5%), cerebrovascular disease in 21 (11%) and chronic lower respiratory disease in 7 (3.7%). In objectives with oncology content, gastrointestinal cancer (16, 28%), non-specific indicators of cancer (7, 12%) and genitourinary/musculoskeletal cancers (6, 10.5%) were most frequent. Content coding had inter-rater agreement greater than 99%, with kappas from 0.73 to 1.00. Oncology was highly represented in the clinical objectives listed for the MCCQE Part 1. With existing research showing limited oncology content on examinations and in medical curricula, our results were unexpected. This finding could signal the efficacy of initiatives seeking to improve oncology education and emphasizes the importance of continuing improvements in oncology education to meet patient and healthcare system needs.

Medical Oncology Education in Egypt Over the Past 50 Years: the Experience of the National Cancer Institute of Cairo University.

This manuscript outlines the progress of education in the field of medical oncology in Egypt over the past 50 years. The manuscript illustrates the origin of the Egyptian medical oncology program since the creation of the only specialized cancer center in the country, the National Cancer Institute of Cairo University (NCI-Cairo) in 1969, from Cairo University Medical School. The manuscript also outlines the NCI-Cairo’s educational program for developing a cadre of academic medical oncologists for NCI-Cairo, other Egyptian medical institutions, and countries in the Middle East and Africa. We also emphasize the capacity building that resulted over the past 50 years from academic and professional standpoints, the changing curriculum in medical oncology, and the differences between the medical oncology and clinical oncology education programs in the country. Medical oncology research resulted from international collaborations and highlighted needs for cancer prevention and control. Finally, we propose possible future directions for medical oncology education and research in the country and a roadmap for low- and middle-income countries (LMICs) that are developing their medical oncology programs.

Design, implementation, and assessment of an online-based oncology education program for medical students: An ASCO Oncology Student Interest Group initiative.

11024 Background: Undergraduate medical education in oncology is often fragmented and non-standardized among medical schools (BMC Med Educ 17:100, 2017). Oncology education initiatives are thus critically needed to increase cancer awareness and improve medical students’ understanding of the principles and multidisciplinary approach of oncology. We designed and implemented an online education program with the aim of providing medical students with an early exposure to the field of oncology. Our program was adapted from the Australian Ideal Oncology Curriculum for Medical Schools and included six sessions covering the basics of cancer biology, prevention and screening, diagnosis and patient management, principles of treatment modalities, principles of surgical oncology, as well as counselling and communications skills. Methods: Medical students at our institution were invited to participate. We also invited medical students from other faculties via the support of student groups namely the nation’s medical student union and our ASCO Oncology Student Interest Group (OSIG). Invitations were sent by email and/or via social media along with a brochure outlining the conference’s program and instructions to use the Zoom platform. Students were asked to voluntarily fill online pre- and post-conference anonymous surveys. Students self-assessed their competency, personal attributes, future career aspirations, and provided an evaluation of the program. A five-point Likert scale was used for most questions, in which 1 indicated strong disagreement and 5 indicated strong agreement with the statement. Results: Nearly 300 students from over 50 medical schools in Turkey attended the live program. Only students (n = 228) who completed both the pre- and post-conference surveys were included in our study. ASCO OSIG members made up 24.1% (n = 55) of the students. Among the participants, 73.7% (n = 168) were preclinical students (years 1-3) and 26.3% (n = 60) were clinical students (years 4-6). Students’ overall self-reported rating of their knowledge significantly improved in each of the six sessions, with the greatest pre-post difference observed for diagnosis and patient management (2.51 ± 1 vs 3.87 ± 0.81) followed by principles of treatment modalities (2.54 ± 0.96 vs 3.79 ± 0.88), P &lt; 0.001. Most students believed the program was beneficial in improving their current understanding of oncology with a mean of 4.43 ± 0.76. Most students (92.5%) were “likely” or “very likely” to recommend the program to their colleagues. Conclusions: Students’ evaluation of the online oncology program demonstrated significant benefit and knowledge improvement. Our successfully piloted teaching model of oncology for medical students can be adapted and implemented at medical schools globally. Further development and continuation of our educational initiative is undergoing.

The Johns Hopkins Molecular Tumor Board Precision Oncology elective for Medical Oncology fellows.

11035 Background: The accelerated impact of next generation sequencing (NGS) in clinical decision making requires the integration of cancer genomics and precision oncology focused training into medical oncology education. The Johns Hopkins Molecular Tumor Board (JH MTB) is a multi-disciplinary effort focused on integration of NGS findings with critical evidence interpretation to generate personalized recommendations tailored to the genetic footprint of individual patients. Methods: The JH MTB and the Medical Oncology Fellowship Program have developed a 3-month precision oncology elective for fellows in their research years. Commencing fall of 2020, the goals of this elective are to enhance the understanding of NGS platforms and findings, advance the interpretation and characterization of molecular assay outputs by use of mutation annotators and knowledgebases and ultimately master the art of matching NGS findings with available therapies. Fellow integration into the MTB focuses on mentored case-based learning in mutation characterization and ranking by levels of evidence for actionability, with culmination in form of verbal presentations and written summary reports of final MTB recommendations. A mixed methods questionnaire was administered to evaluate progress since elective initiation. Results: Three learners who have participated as of February 2021 were included. Of the two who had completed the MTB elective, each have presented at least 10 cases, with at least 1 scholarly publication planned. All indicated strong agreement that MTB elective had increased their comfort with interpreting clinical NGS reports as well as the use of knowledgebases and variant annotators. Exposure to experts in the field of molecular precision oncology, identification of resources necessary to interpret clinical NGS reports, development of ability to critically assess various NGS platforms, and gained familiarity with computational analyses relevant to clinical decision making were noted as strengths of the MTB elective. Areas of improvement included ongoing initiatives that involve streamlining variant annotation and transcription of information for written reports. Conclusions: A longitudinal elective in the JHU MTB has been found to be preliminarily effective in promoting knowledge mastery and creating academic opportunities related to the clinical application of precision medicine. Future directions will include leveraging of the MTB infrastructure for research projects, learner integration into computational laboratory meetings, and expansion of the MTB curriculum to include different levels of learners from multiple medical education programs. Continued elective participation will be key to understanding how best to facilitate adaptive expertise in assigning clinical relevance to genomic findings, ultimately improving precision medicine delivery in patient care and trial development.

Alignment of Regulatory Examinations and Public Health Priorities: Exploring the Representation of Cancer on the MCCQE-1

Cancer is the leading cause of death in Canada - yet research has demonstrated that medical education in oncology is perceived as inadequate by learners, educators and generalist physicians. The Medical Council of Canada (MCC) conducts two examinations as Canada’s national standard of assessment of medical graduates. This study aimed to determine the representation of topics in the Medical Council of Canada Qualifying Examination – Part 1 (MCCQE-1) objectives with respect to leading public health priorities, including cancer. Based on current literature, our hypothesis is that cancer will be underrepresented as an objective topic in the MCCQE-1 compared to other leading disease priorities. The MCCQE-1 lists roles in which medical graduates should be competent. The focus of this study was the “Medical Expert” role and its associated testable objectives. A deductive coding method, using NVivo 11 software, was used to map these objectives for the representation of leading Canadian health priorities – specifically oncology, cardiology, cerebrovascular disease and chronic lower respiratory disease. Using the International Statistical Classification of Diseases and Related Health problems, 10th edition (ICD-10, WHO, 2016), in conjunction with reports on the leading causes of death in Canada, key terms for the above-mentioned health priorities were determined. Two coders analyzed the data to increase objectivity and reduce bias. Mapping of the MCCQE-1 objectives found 190 discreet topics listed under the Medical Expert objectives section. Of those 190, oncology content was found in 57 (30%), cardiovascular diseases in 56 (29.5%), cerebrovascular diseases in 21 (11%) and chronic lower respiratory diseases in 7 (3.7%) respectively. Within the 57 objectives containing oncology content, the three most frequently mentioned cancer sites were gastrointestinal (16/57, 23%), followed by generalized/nonspecific indicators of cancer (7/57, 12%) and genitourinary/musculoskeletal cancers (6/57 each, or 10.5%). The mapping of each disease content by two coders had inter rater agreement greater than 99%, with Kappa values ranging from 0.73 – 1.00, indicating substantial agreement. Findings suggest that top public health concerns in Canada are highly represented in the MCCQE-1 examination. Further work is needed to understand the mismatch between content representation on the MCCQE-1 and perceptions of learners, educators and generalist physicians regarding inadequate education in cancer.

Author Index

Asia-Pacific Journal of Clinical OncologyVolume 15, Issue S5 p. 101-104 AUTHOR INDEX Author Index First published: 05 August 2019 https://doi.org/10.1111/ajco.13219Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Volume15, IssueS5Special Issue: Medical Oncology Group of Australia Incorporated 40th Anniversary Annual Scientific Meeting, Leading the Way in Medical Oncology Education, Research and Clinical Practice, 14–16 August 2019, National Canberra Convention Centre, Canberra, AustraliaAugust 2019Pages 101-104 RelatedInformation

Plenary Session – Best of the Best Research 2019 Abstracts

Asia-Pacific Journal of Clinical OncologyVolume 15, Issue S5 p. 66-70 ABSTRACTS Plenary Session – Best of the Best Research 2019 Abstracts First published: 05 August 2019 https://doi.org/10.1111/ajco.13217Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Volume15, IssueS5Special Issue: Medical Oncology Group of Australia Incorporated 40th Anniversary Annual Scientific Meeting, Leading the Way in Medical Oncology Education, Research and Clinical Practice, 14–16 August 2019, National Canberra Convention Centre, Canberra, AustraliaAugust 2019Pages 66-70 RelatedInformation

Poster Abstracts

Asia-Pacific Journal of Clinical OncologyVolume 15, Issue S5 p. 71-100 ABSTRACTS Poster Abstracts First published: 05 August 2019 https://doi.org/10.1111/ajco.13218Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Volume15, IssueS5Special Issue: Medical Oncology Group of Australia Incorporated 40th Anniversary Annual Scientific Meeting, Leading the Way in Medical Oncology Education, Research and Clinical Practice, 14–16 August 2019, National Canberra Convention Centre, Canberra, AustraliaAugust 2019Pages 71-100 RelatedInformation

Medical Oncology Group of Australia Incorporated‐Executive Committee

Asia-Pacific Journal of Clinical OncologyVolume 15, Issue S5 p. 20-21 MEDICAL ONCOLOGY GROUP OF AUSTRALIA INCORPORATED-EXECUTIVE COMMITTEE Medical Oncology Group of Australia Incorporated-Executive Committee First published: 05 August 2019 https://doi.org/10.1111/ajco.13204Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume15, IssueS5Special Issue: Medical Oncology Group of Australia Incorporated 40th Anniversary Annual Scientific Meeting, Leading the Way in Medical Oncology Education, Research and Clinical Practice, 14–16 August 2019, National Canberra Convention Centre, Canberra, AustraliaAugust 2019Pages 20-21 RelatedInformation

Immuno-Oncology Forum.

Asia-Pacific Journal of Clinical OncologyVolume 15, Issue S5 p. 51-51 IMMUNO-ONCOLOGY FORUM Immuno-Oncology Forum First published: 05 August 2019 https://doi.org/10.1111/ajco.13213Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume15, IssueS5Special Issue: Medical Oncology Group of Australia Incorporated 40th Anniversary Annual Scientific Meeting, Leading the Way in Medical Oncology Education, Research and Clinical Practice, 14–16 August 2019, National Canberra Convention Centre, Canberra, AustraliaAugust 2019Pages 51-51 RelatedInformation

Program at a Glance

Asia-Pacific Journal of Clinical OncologyVolume 15, Issue S5 p. 42-44 PROGRAM IN DETAIL Program at a Glance First published: 05 August 2019 https://doi.org/10.1111/ajco.13211Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume15, IssueS5Special Issue: Medical Oncology Group of Australia Incorporated 40th Anniversary Annual Scientific Meeting, Leading the Way in Medical Oncology Education, Research and Clinical Practice, 14–16 August 2019, National Canberra Convention Centre, Canberra, AustraliaAugust 2019Pages 42-44 RelatedInformation

Scientific Program.

Asia-Pacific Journal of Clinical OncologyVolume 15, Issue S5 p. 45-50 SCIENTIFIC PROGRAM Scientific Program First published: 05 August 2019 https://doi.org/10.1111/ajco.13212Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Volume15, IssueS5Special Issue: Medical Oncology Group of Australia Incorporated 40th Anniversary Annual Scientific Meeting, Leading the Way in Medical Oncology Education, Research and Clinical Practice, 14–16 August 2019, National Canberra Convention Centre, Canberra, AustraliaAugust 2019Pages 45-50 RelatedInformation

National Speakers.

Asia-Pacific Journal of Clinical OncologyVolume 15, Issue S5 p. 33-41 NATIONAL SPEAKERS National Speakers First published: 05 August 2019 https://doi.org/10.1111/ajco.13210Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Volume15, IssueS5Special Issue: Medical Oncology Group of Australia Incorporated 40th Anniversary Annual Scientific Meeting, Leading the Way in Medical Oncology Education, Research and Clinical Practice, 14–16 August 2019, National Canberra Convention Centre, Canberra, AustraliaAugust 2019Pages 33-41 RelatedInformation

Convenor's Welcome.

Asia-Pacific Journal of Clinical OncologyVolume 15, Issue S5 p. 7-7 CONVENOR'S WELCOME Convenor's Welcome First published: 05 August 2019 https://doi.org/10.1111/ajco.13200Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume15, IssueS5Special Issue: Medical Oncology Group of Australia Incorporated 40th Anniversary Annual Scientific Meeting, Leading the Way in Medical Oncology Education, Research and Clinical Practice, 14–16 August 2019, National Canberra Convention Centre, Canberra, AustraliaAugust 2019Pages 7-7 RelatedInformation

AOL-3 - Medical oncology group of Australia: taking a leading role in medical oncology education, patient care & research

Background: The Medical Oncology Group of Australia (MOGA) is the leading professional organisation for medical oncology in Australia and is a specialty society of the Royal Australasian College of Physicians. Founded in 1973, MOGA is the key point of reference on all matters relating to medical oncology education, patient management and research in Australia. Membership: MOGA brings together 660 medical oncologists (519 consultants: 141 trainees); representing approximately 98% of the Australian medical oncology workforce. Supporting members: MOGA supports its members through: “Post-graduate medical oncology training; “Developing career development initiatives; “Developing Scientific and Academic meetings, programs & workshops; “Contributing to the development and promotion of evidence-based standards for cancer care, management and clinical practice; “Advocacy, lobbying and professional representation; “Research activities and special projects; and “Consumer and Community Support via key organisations. Education and research: MOGA takes a leading role in advancing medical oncology training and education through several initiatives including; Communications Skills Training, Young Oncologists Education Programs, a Sciences of Oncology Program as well as an Annual Scientific Meeting. MOGA organises the Australia Asia Pacific Oncology Research Development (ACORD) Workshop that has trained more than 498 oncology professionals in clinical trials design. Patient management and clinical practice: MOGA is committed to ensuring that the highest standards of international best practice clinical care. Initiatives include the preparation and dissemination of practice guidelines and tools, and advocacy through major organisations. MOGA is proactive in working for oncology treatment access. Conclusion: MOGA takes pride in its place as a hub for all Australian medical oncology issues nationally, speaking with a strong voice for the discipline and members of the profession.